semaglutide mash GLP-1 BREAKTHROUGH: FDA APPROVES TREATMENT FOR SERIOUS LIVER DISEASE Semaglutide, a medication already known for its role in weight management, is now the first GLP-1 therapy approved to treat (Metabolic Dysfunction–Associated Novo Nordisk's Wegovy gets accelerated

M.BaluD.Avila-MunozE.AbdullahL.ThomasR.CollinsN.et al

Do not use Wegovy if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Kansanen et al., 2013)

These findings have led to NICE recommendations supporting the use of certain GLP-1 receptor agonists in patients with type 2 diabetes and established cardiovascular disease or at high cardiovascular risk

Research citations current as of June 2026

Wegovy Ozempic and Wegovy both contain the same active ingredient, semaglutide